1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Genomics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Genomics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Genomics Market Regional Analysis
6.2 Europe Genomics Market Revenue 2017-2027 (US$ Million)
6.3 Europe Genomics Market Forecast Analysis
7. Europe Genomics Market Analysis – by Technology
7.1 Sequencing
- 7.1.1 Overview
- 7.1.2 Sequencing: Europe Genomics Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Microarray
- 7.2.1 Overview
- 7.2.2 Microarray: Europe Genomics Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Polymerase chain reaction
- 7.3.1 Overview
- 7.3.2 Polymerase chain reaction: Europe Genomics Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Nucleic Acid Extraction and Purification
- 7.4.1 Overview
- 7.4.2 Nucleic Acid Extraction and Purification: Europe Genomics Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Europe Genomics Market Analysis – by Product & Service
8.1 Instruments/Systems
- 8.1.1 Overview
- 8.1.2 Instruments/Systems: Europe Genomics Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Consumables
- 8.2.1 Overview
- 8.2.2 Consumables: Europe Genomics Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Services
- 8.3.1 Overview
- 8.3.2 Services: Europe Genomics Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Europe Genomics Market Analysis – by Application
9.1 Diagnostics
- 9.1.1 Overview
- 9.1.2 Diagnostics: Europe Genomics Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Drug Discovery and Development
- 9.2.1 Overview
- 9.2.2 Drug Discovery and Development: Europe Genomics Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Precision/Personalized Medicine
- 9.3.1 Overview
- 9.3.2 Precision/Personalized Medicine: Europe Genomics Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.4 Agriculture & Animal Research
- 9.4.1 Overview
- 9.4.2 Agriculture & Animal Research: Europe Genomics Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. Europe Genomics Market Analysis – by End User
10.1 Research Centers
- 10.1.1 Overview
- 10.1.2 Research Centers: Europe Genomics Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.2 Hospitals and Clinics
- 10.2.1 Overview
- 10.2.2 Hospitals and Clinics: Europe Genomics Market – Revenue and Forecast, 2017-2027 (US$ Million)
10.3 Pharmaceutical & Biotechnology Companies
- 10.3.1 Overview
- 10.3.2 Pharmaceutical & Biotechnology Companies: Europe Genomics Market – Revenue and Forecast, 2017-2027 (US$ Million)
11. Europe Genomics Market – Europe Analysis
11.1 Overview
11.2 Europe
- 11.2.1 Europe Genomics Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 11.2.1.1 Europe Genomics Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 UK:
Europe Genomics Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.1.1 UK: Europe Genomics Market Breakdown, by Technology
- 11.2.1.1.2 UK: Europe Genomics Market Breakdown, by Product & Service
- 11.2.1.1.3 UK: Europe Genomics Market Breakdown, by Application
- 11.2.1.1.4 UK: Europe Genomics Market Breakdown, by End User
- 11.2.1.2 Germany:
Europe Genomics Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.2.1 Germany: Europe Genomics Market Breakdown, by Technology
- 11.2.1.2.2 Germany: Europe Genomics Market Breakdown, by Product & Service
- 11.2.1.2.3 Germany: Europe Genomics Market Breakdown, by Application
- 11.2.1.2.4 Germany: Europe Genomics Market Breakdown, by End User
- 11.2.1.3 France:
Europe Genomics Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.3.1 France: Europe Genomics Market Breakdown, by Technology
- 11.2.1.3.2 France: Europe Genomics Market Breakdown, by Product & Service
- 11.2.1.3.3 France: Europe Genomics Market Breakdown, by Application
- 11.2.1.3.4 France: Europe Genomics Market Breakdown, by End User
- 11.2.1.4 Russia:
Europe Genomics Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.4.1 Russia: Europe Genomics Market Breakdown, by Technology
- 11.2.1.4.2 Russia: Europe Genomics Market Breakdown, by Product & Service
- 11.2.1.4.3 Russia: Europe Genomics Market Breakdown, by Application
- 11.2.1.4.4 Russia: Europe Genomics Market Breakdown, by End User
- 11.2.1.5 Italy:
Europe Genomics Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.5.1 Italy: Europe Genomics Market Breakdown, by Technology
- 11.2.1.5.2 Italy: Europe Genomics Market Breakdown, by Product & Service
- 11.2.1.5.3 Italy: Europe Genomics Market Breakdown, by Application
- 11.2.1.5.4 Italy: Europe Genomics Market Breakdown, by End User
- 11.2.1.6 Rest of Europe:
Europe Genomics Market – Revenue and Forecast to 2027 (US$ Million)
- 11.2.1.6.1 Rest of Europe: Europe Genomics Market Breakdown, by Technology
- 11.2.1.6.2 Rest of Europe: Europe Genomics Market Breakdown, by Product & Service
- 11.2.1.6.3 Rest of Europe: Europe Genomics Market Breakdown, by Application
- 11.2.1.6.4 Rest of Europe: Europe Genomics Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Illumina, Inc.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Danaher
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 BIO-RAD LABORATORIES INC.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 General Electric Company
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 THERMO FISHER SCIENTIFIC INC.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Agilent Technologies, Inc.
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Eurofins Scientific
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 QIAGEN
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 BGI
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations